Search

Search Constraints

You searched for: Author/Creator Scomazzon, Edoardo

Search Results

1. BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome. (5th July 2018)

2. Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. (17th April 2017)

3. Dabigatran in ibrutinib‐treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases. Issue 5 (6th September 2018)

4. HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia. Issue 11 (15th May 2019)

5. Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients. (February 2017)